Primarily responsible for oversight of routine production of both clinical and clinical research PET drug products. Responsible for the development of new PET drug products for clinical research and provides instruction/training to PET Radiochemists and CNMTs. Ensures daily production and quality control of routine PET drugs is carried out accurately and reliably according to standard operating procedures. Completes synthesis of PET drug products for clinical and clinical research studies, as needed. Ensures maintenance of synthesizer modules are completed, when necessary, according to SOP. Assists PET Radiochemistry Supervisor in ensuring analytical and general laboratory equipment is maintained, serviced, and calibrated as necessary. Responsible for ensuring the accuracy and completeness of documentation associated with the production and manufacturing of the PET drug products. Assists the PET Radiochemistry Supervisor in the preparation of documentation associated with manufacture of PET drug products and radionuclides under Food and Drug Administration's Current Good Manufacturing Practice (GMP) guidelines and under USP general chapter for PET drug products. Receives commercial PET drug doses. Assists the PET Radiochemistry Supervisor in the ordering of commercial PET drug doses as needed.

Qualifications: 

Master's degree in chemistry or a chemistry-related field, or a bachelor's degree in chemistry or a chemistry-related field with a minimum of four years' experience producing and/or developing PET drug products. 

Background in analytical chemistry, preferably organic chemistry. 

Experience working with radioactivity such as in a PET radiochemistry laboratory, nuclear medicine environment, or commercial nuclear pharmacy specializing in PET drug production. 

Strong word processing and database skills, specifically with Microsoft Word and Excel.

Prior experience teaching, training, group interactions and presentations.